Essential Thrombocythemia
Differential Diagnosis
Secondary Thrombocythemia
- Splenectomy
- Inflammatory conditions
- Infection
- Connective tissue diseases
- Neoplasms
- Metastatic
- Lymphoproliferative disorders
- Iron deficiency
Hematolymphoid Disorders with Thrombocytosis
| |
CML |
PV |
PMF, Cellular Phase |
ET |
RARS-T |
5q- |
| Tyrosine kinase |
ABL p230 variant* |
JAK2 |
JAK2 or MPL 50% |
JAK2 or MPL 50% |
JAK2 50% |
JAK2 or MPL 10% |
| Blood |
↑PMN, basophils, platelets |
Normo or hypochromatic anemia, may have ↑basophils, platelets |
Anemia, leukocytosis, ↑or nl platelets |
↑platelets, often abnormal |
Dimorphic RBC, ↑platelets |
Macrocytic anemia, ↑or nl platelets |
| Marrow |
↑↑Myeloids, ↑dwarf megas |
Panmyelosis, ±erythroid hyperplasia, atypical megas |
Panmyelosis, atypical tightly clustered megas |
↑↑Megas |
Erythroid dysplasia, ring sideroblasts, ↑megas |
Erythroid hypoplasia, ↑small megas |
| Marrow Fibrosis |
Varies |
↑ in spent phase |
↑↑ in fibrotic phase |
Minimal |
Varies |
Minimal |
| Splenomegaly |
++ |
++ |
+++ |
± |
± |
Absent |
| Clinical/Other |
B symptoms |
Hypertension, thrombosis, pruritus, ↓EPO |
B symptoms, bleeding, gout |
Thrombosis, hemorrhage |
Anemia |
Anemia |
EPO = erythropoietin, * rare p230 BCR-ABL1 isoform can present with thrombocytosis and /or neutrophilia
Essential Thrombocythemia vs Cellular Phase Primary Myelofibrosis vs CML
| |
Essential Thrombocythemia |
Cellular Phase Primary Myelofibrosis |
CML with p230 |
| Cellularity |
Normal to moderately hypercellular |
Markedly hypercellular (cellular phase) |
Markedly hypercellular |
| Megas - Distribution |
Dispersed or loose clusters |
Tight clusters, touching each other |
Dispersed or loose clusters |
| Megas - Size |
Large and giant |
Pleomorphic |
Variable, may have dwarf forms |
| Megas - Nuclei |
Lobulated |
Bulbous, hyperchromatic |
Hypolobated |
| Megas - Cytoplasm |
Mature |
Variable, may have naked nuclei |
Mature |
| Granulopoietic Hyperplasia |
Infrequent, mild |
Moderate to marked in cellular phase |
Marked |
| Splenomegaly |
Infrequent |
Frequent |
Rare |
| JAK2V617I |
Allele burden <50% |
Allele burden >50% |
|
Megas = megakaryocytes
Common Myeloproliferative Neoplasms - Overview
| |
CML |
PV |
PMF |
ET |
| Tyrosine kinase |
ABL |
JAK2 |
JAK2 or MPL |
JAK2 or MPL |
| Blood |
↑WBC with IG, basophils |
Normo or hypochromatic anemia, may have ↑platelets & basophils |
Leukoerythroblastic with teardrops |
↑Platelets, often abnormal |
| Marrow |
↑↑Myeloids |
Panmyelosis, ± erythroid hyperplasia, atypical megas |
Panmyelosis, atypical megas |
↑↑Megas |
| Marrow fibrosis |
Varies |
↑In spent phase |
↑↑In fibrotic phase |
Minimal |
| Splenomegaly |
++ |
++ |
+++ |
± |
| Clinical Presentation /Other |
B symptoms |
Hypertension, thrombosis, pruritus,↓EPO |
B symptoms, bleeding, gout |
Thrombosis, hemorrhage |
CML = chronic myeloid leukemia; PV = polycythemia vera; PMF = primary myelofibrosis; ET = essential thrombocythemia; IG = immature granulocytes; Megas = megakaryocytes; EPO = erythropoietin
Common Myeloproliferative Neoplasms - Peripheral Blood
| |
CML |
PV |
Cellular Phase PMF |
ET |
| RBC |
Normal or ↓ |
Normal, ↑ or ↓, may be hypochromatic or polychromatic |
↓, teardrop cells |
Normal or ↓ (iron deficient anemia) |
| WBC |
↑, left shifted, basophilia, eosinophilia, rarely monocytosis |
Normal or ↑, +/- basophils, (leukoerythroblastic ini fibrotic stage) |
↑granulocytes if leukoerythroblastic |
Normal |
| Platelets |
Normal or ↑ |
Normal or ↑ |
Normal or ↑ |
↑ (>450 x103/μL) |
CML = chronic myeloid leukemia; PV = polycythemia vera; PMF = primary myelofibrosis; ET = essential thrombocythemia